| Trial Identifier: | D2287C00013 |
| Sponsor: | AstraZeneca |
| Start Date: | June 2026 |
| Primary Completion Date: | June 2027 |
| Study Completion Date: | June 2027 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| CN | Beijing, CN, 100000 |
| CN | Changsha, CN, 430033 |
| CN | Chengdu, CN, 610041 |
| CN | chongqing, CN, 400016 |
| CN | Guangzhou, CN, 510120 |
| CN | Guangzhou, CN, 510000 |
| CN | Guangzhou, CN, 510630 |
| CN | Kunming, CN, 650032 |
| CN | quanzhou, CN, 362000 |
| CN | Shanghai, CN, 200080 |
| CN | Shanghai, CN, 200065 |
| CN | Shanghai, CN, 200032 |
| CN | suzhou, CN, 215006 |
| CN | Taiyuan, CN, 030001 |
| CN | Tianjin, CN, 300192 |
| CN | Wuhan, CN, 430048 |
| CN | XI'AN, CN, 710004 |
| CN | Zhengzhou, CN, 450000 |
| CN | zhuhai, CN, 519000 |